Terms: = Endocrine gland cancer AND ALDH2, ALDHI, 217, ENSG00000111275, ALDH-E2, P05091, MGC1806, ALDM AND Prognosis
52 results:
1. Factors Associated with Survival in Anaplastic Thyroid Carcinoma: A Multicenter Study from the ENDOCAN-TUTHYREF Network.
Jannin A; Giudici F; de la Fouchardière C; Al Ghuzlan A; Wassermann J; Chougnet CN; Drui D; Godbert Y; Ilouz F; Bardet S; Zanetta S; Roudaut N; Batisse Lignier M; Groussin L; Klein M; Zerdoud S; Lamartina L; Baudin E; Decaussin-Petrucci M; Leteurtre E; Borson Chazot F; Do Cao C; Borget I; Hadoux J;
Thyroid; 2023 Oct; 33(10):1190-1200. PubMed ID: 37855745
[No Abstract] [Full Text] [Related]
2. Searching for prognostic markers for Stage I epithelial ovarian cancer: A role for systemic inflammatory markers.
Borella F; Bertero L; Valabrega G; Fucina S; Cassoni P; Benedetto C
Int J Gynaecol Obstet; 2024 Jan; 164(1):262-269. PubMed ID: 37496460
[TBL] [Abstract] [Full Text] [Related]
3. Radiotherapy in recurrent ovarian cancer: updated results of involved-field radiation therapy.
Lee BM; Lee SJ; Kim N; Byun HK; Kim YB
Int J Gynecol Cancer; 2023 Jul; 33(7):1106-1111. PubMed ID: 37217239
[TBL] [Abstract] [Full Text] [Related]
4. LILRB1
Xu X; Yin S; Wang Y; Zhu Q; Zheng G; Lu Y; Li T; Zhu C
Int Immunopharmacol; 2023 Jun; 119():110162. PubMed ID: 37075669
[TBL] [Abstract] [Full Text] [Related]
5. SDHB immunohistochemistry for prognosis of pheochromocytoma and paraganglioma: A retrospective and prospective analysis.
Su T; Yang Y; Jiang L; Xie J; Zhong X; Wu L; Jiang Y; Zhang C; Zhou W; Ye L; Ning G; Wang W
Front Endocrinol (Lausanne); 2023; 14():1121397. PubMed ID: 37008946
[TBL] [Abstract] [Full Text] [Related]
6. Platelet-Lymphocyte and Neutrophil-Lymphocyte Ratios Are Prognostic Markers for Pheochromocytomas and Paragangliomas.
Zhong X; Su T; Yang Y; Ye L; Jiang L; Qi Y; Xie J; Jiang Y; Zhou W; Zhang C; Wu L; Zhu H; Ning G; Wang W
J Clin Endocrinol Metab; 2023 Aug; 108(9):2230-2239. PubMed ID: 36917004
[TBL] [Abstract] [Full Text] [Related]
7. PD-L1 is highly expressed in ovarian cancer and associated with cancer stem cells populations expressing CD44 and other stem cell markers.
Alwosaibai K; Aalmri S; Mashhour M; Ghandorah S; Alshangiti A; Azam F; Selwi W; Gharaibeh L; Alatawi Y; Alruwaii Z; Alsaab HO
BMC Cancer; 2023 Jan; 23(1):13. PubMed ID: 36604635
[TBL] [Abstract] [Full Text] [Related]
8. Proteogenomic insights into the biology and treatment of pancreatic ductal adenocarcinoma.
Tong Y; Sun M; Chen L; Wang Y; Li Y; Li L; Zhang X; Cai Y; Qie J; Pang Y; Xu Z; Zhao J; Zhang X; Liu Y; Tian S; Qin Z; Feng J; Zhang F; Zhu J; Xu Y; Lou W; Ji Y; Zhao J; He F; Hou Y; Ding C
J Hematol Oncol; 2022 Nov; 15(1):168. PubMed ID: 36434634
[TBL] [Abstract] [Full Text] [Related]
9. Analysis of Delayed Surgery and Clinical Outcomes in Intermediate- and High-risk Papillary Thyroid cancer.
Zhou H; Wu J; Shi L; Wang Y; Liu B
J Clin Endocrinol Metab; 2022 Nov; 107(12):3389-3397. PubMed ID: 36056633
[TBL] [Abstract] [Full Text] [Related]
10. Robotic versus open pancreaticoduodenectomy for distal cholangiocarcinoma: a multicenter propensity score-matched study.
Xu S; Zhang XP; Zhao GD; Zou WB; Zhao ZM; Hu MG; Gao YX; Tan XL; Liu Q; Liu R
Surg Endosc; 2022 Nov; 36(11):8237-8248. PubMed ID: 35534733
[TBL] [Abstract] [Full Text] [Related]
11. Diabetes duration and weight loss are associated with onset age and remote metastasis of pancreatic cancer in patients with diabetes mellitus.
Ma M; Li W; Xu L; Ping F; Zhang H; Li Y
J Diabetes; 2022 Apr; 14(4):261-270. PubMed ID: 35167190
[TBL] [Abstract] [Full Text] [Related]
12. [Comparison of clinical characteristics between sporadic gastrinoma and multiple endocrine neoplasia type 1-related gastrinoma].
Guo Y; Chen LH; Liu M; Zhang YX; Zhang N; Chen J
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Oct; 24(10):875-882. PubMed ID: 34674462
[No Abstract] [Full Text] [Related]
13. LncRNA CERS6-AS1 promotes proliferation and metastasis through the upregulation of YWHAG and activation of ERK signaling in pancreatic cancer.
Xu J; Wang J; He Z; Chen P; Jiang X; Chen Y; Liu X; Jiang J
Cell Death Dis; 2021 Jun; 12(7):648. PubMed ID: 34168120
[TBL] [Abstract] [Full Text] [Related]
14. The novel index using preoperative C-reactive protein and neutrophil-to-lymphocyte ratio predicts poor prognosis in patients with pancreatic cancer.
Taniai T; Haruki K; Furukawa K; Onda S; Yasuda J; Shirai Y; Gocho T; Yanagaki M; Hamura R; Shiba H; Ikegami T
Int J Clin Oncol; 2021 Oct; 26(10):1922-1928. PubMed ID: 34110531
[TBL] [Abstract] [Full Text] [Related]
15. The levels of soluble cMET ectodomain in the blood of patients with ovarian cancer are an independent prognostic biomarker.
Klotz DM; Link T; Goeckenjan M; Wimberger P; Kuhlmann JD
Mol Oncol; 2021 Sep; 15(9):2491-2503. PubMed ID: 33690968
[TBL] [Abstract] [Full Text] [Related]
16. The age threshold of the 8th edition AJCC classification is useful for indicating patients with aggressive papillary thyroid cancer in clinical practice.
Kaliszewski K; Diakowska D; Nowak Ł; Wojtczak B; Rudnicki J
BMC Cancer; 2020 Nov; 20(1):1166. PubMed ID: 33256657
[TBL] [Abstract] [Full Text] [Related]
17. Expression of selected microRNAs in pancreatic ductal adenocarcinoma: is there a relation to tumor morphology, progression and patient's outcome?
Szabo A; Gurlich R; Liberko M; Soumarova R; Vernerova Z; Mandys V; Popov A
Neoplasma; 2020 Sep; 67(5):1170-1181. PubMed ID: 32567937
[TBL] [Abstract] [Full Text] [Related]
18. Efficacy of Staging Laparoscopy for Pancreatic cancer.
Yamamura K; Yamashita YI; Yamao T; Kuroda D; Eto T; Kitano Y; Arima K; Miyata T; Okabe H; Nitta H; Hashimoto D; Baba H
Anticancer Res; 2020 Feb; 40(2):1023-1027. PubMed ID: 32014948
[TBL] [Abstract] [Full Text] [Related]
19. Management and clinical outcomes of patients with recurrent/progressive ovarian clear cell carcinoma.
Huang HJ; Yang LY; Tung HJ; Ku FC; Wu RC; Tang YH; Chang WY; Jung SM; Wang CC; Lin CT; Liu FY; Lin G; Chen MY; Chou HH; Chang TC; Chao A; Lai CH
J Formos Med Assoc; 2020 Apr; 119(4):793-804. PubMed ID: 31818713
[TBL] [Abstract] [Full Text] [Related]
20. Circular RNA ADAM9 facilitates the malignant behaviours of pancreatic cancer by sponging miR-217 and upregulating PRSS3 expression.
Xing C; Ye H; Wang W; Sun M; Zhang J; Zhao Z; Jiang G
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3920-3928. PubMed ID: 31810373
[TBL] [Abstract] [Full Text] [Related]
[Next]
